Improve Your Commercial Growth Strategy with Custom-Tailored Intelligence

LEARN MORE

The Only Life Science Intelligence Platform Precisely Tailored to You


At Amplion, we’re driven by a passion for accelerating drug discovery and development. That’s why we’ve built the only intelligence platform that leverages machine learning and user-level customization to identify opportunities matched precisely to your goals.
Meet Amplion: the World's Smartest  Biomedical Intelligence Platform
32 Million 
Evidence Sources
Analyzed
20,000 
Life Science Orgs
Tracked


85,000 
Active Clinical Trials Monitored

30,000 
New Research Pubs Analyzed Weekly
Amplion Intelligence for Revenue Teams

Identifying Qualified Opportunities is Key to Growth – It’s Also a Significant Challenge
Developing high-value commercial opportunities can be slow and costly without a proactive, targeted strategy. Amplion’s Intelligence Platform uses machine learning to discover timely, relevant opportunities tailored to your specific needs so you can plan and drive predictable growth.

    Industry Insights
    Companion Diagnostics Biomarker Trends

    The CDx Trends Report details how biomarker-based tests are currently being used to identify patients and to guide drug dosing and safety.

    Clinical Development Success Rates

    Amplion, BIO, and BioMedTracker release new report on ground breaking role biomarkers have in tripling clinical trial Likelihood of Approval (LOA) rates.

    Success in Precision Medicine
    Success in Precision Medicine covers the growing importance of biomarkers in precision medicine and outlines the challenge of transitioning to targeted therapies.
    PageLines